​

Werewolf Therapeutics (HOWL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Werewolf Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$21.00M

Main Segment (Y)

Reportable Segment

Werewolf Therapeutics Revenue by Period

Werewolf Therapeutics Revenue by Year

DateRevenueChange
2025-12-31--100.00%
2024-12-31$1.89M-90.55%
2023-12-31$19.94M21.60%
2022-12-31$16.40M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Werewolf Therapeutics generated - in revenue during NA 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Werewolf Therapeutics Revenue by Quarter

DateRevenueChange
2026-06-30$21.00M100.00%
2026-03-31-100.00%
2025-12-31-100.00%
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31-100.00%
2024-09-30--100.00%
2024-06-30$1.14M54.04%
2024-03-31$742.00K-50.57%
2023-12-31$1.50M-74.55%
2023-09-30$5.90M-27.03%
2023-06-30$8.08M81.03%
2023-03-31$4.46M-38.71%
2022-12-31$7.28M46.54%
2022-09-30$4.97M19.82%
2022-06-30$4.15M100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Werewolf Therapeutics generated $21.00M in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Werewolf Therapeutics Revenue Breakdown

Werewolf Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Reportable Segment$1.89M

Werewolf Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Reportable Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 26
Reportable Segment$21.00M

Werewolf Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Reportable Segment (100.00%).

Werewolf Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
OTLKOutlook Therapeutics$1.41T$9.00K
CUECue Biopharma$27.47M$7.88M
NRXPNRx Pharmaceuticals$1.23M$1.10M
INMBINmune Bio$14.00K-
OSTXOS Therapies--
SPRBSpruce Biosciences--
IOBTIO Biotech--
ACETAdicet Bio--
LITSLite Strategy--
HOWLWerewolf Therapeutics-$21.00M

HOWL Revenue FAQ

What is Werewolf Therapeutics’s yearly revenue?

Werewolf Therapeutics's yearly revenue for 2025 was $0, representing a decrease of -100.00% compared to 2024. The company's yearly revenue for 2024 was $1.88M, representing a decrease of -90.55% compared to 2023. HOWL's yearly revenue for 2023 was $19.94M, representing an increase of 21.60% compared to 2022.

What is Werewolf Therapeutics’s quarterly revenue?

Werewolf Therapeutics's quarterly revenue for Q2 2026 was $21M, a 100.00% increase from the previous quarter (Q1 2026), and a 0% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $0, a 100.00% increase from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). HOWL's quarterly revenue for Q4 2025 was $0, a 100.00% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024).

What is Werewolf Therapeutics’s revenue growth rate?

Werewolf Therapeutics's revenue growth rate for the last 3 years (2023-2025) was -100.00%, and for the last 5 years (2021-2025) was 0%.

What are Werewolf Therapeutics’s revenue streams?

Werewolf Therapeutics's revenue streams in c 24 are Reportable Segment

What is Werewolf Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Werewolf Therapeutics was Reportable Segment. This segment made a revenue of $1.88M, representing 100.00% of the company's total revenue.